阿帕替尼联合替吉奥治疗晚期胃癌1例

图 1 2015年4月与2016年4月纵隔淋巴结CT

Figure 1. CT features of mediastinal lymph nodes in April 2015 and April 2016

A. Before treatment; B. After treatment

下载: 全尺寸图片幻灯片

图 2 2015年4月与2016年4月颈部淋巴结CT

Figure 2. CT features of cervical lymph nodes in April 2015 and April 2016

A. Before treatment; B. After treatment

下载: 全尺寸图片幻灯片

[1]	Zhang H. Apatinib for molecular targeted therapy in tumor[J]. Drug Des Devel Ther, 2015, 9(11):6075-6081. https://www.ncbi.nlm.nih.gov/pubmed/26622168
[2]	井小会.阿帕替尼联合替吉奥一线治疗老年晚期胃癌[J].中国实用医刊, 2016, 43(10):37-39. doi: 10.3760/cma.j.issn.1674-4756.2016.10.017 Jing XH. Effect of apatinib combined with TS-1 as first-line therapy on elderly patients with advanced gastric cancer[J]. Chin J Prac Med, 2016, 43(10):37-39. doi: 10.3760/cma.j.issn.1674-4756.2016.10.017
[3]	秦叔逵, 李进.阿帕替尼治疗胃癌的临床应用专家共识[J].临床肿瘤学杂志, 2015, 20(9):841-847. http://www.cnki.com.cn/Article/CJFDTOTAL-LCZL201509014.htm Qin SK, Li J. Experts consensus on the clinical application of apatinib in gastric cancer treatment[J]. Chin Clin Oncol, 2015, 20(9):841-847. http://www.cnki.com.cn/Article/CJFDTOTAL-LCZL201509014.htm